Cost-effectiveness analysis comparing repetitive transcranial magnetic stimulation therapy with antidepressant treatment in patients with treatment-resistant depression in Japan

Yoshihiro Noda, Chiaki Miyashita, Yoko Komatsu, Shinsuke Kito, Masaru Mimura
doi: https://doi.org/10.1101/2022.12.02.22282995

Article Information

doi 
https://doi.org/10.1101/2022.12.02.22282995
History 
  • December 6, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Yoshihiro Noda1,*,
  2. Chiaki Miyashita2,
  3. Yoko Komatsu2,
  4. Shinsuke Kito3 and
  5. Masaru Mimura1
  1. 1Department of Neuropsychiatry, Keio University School of Medicine
  2. 2Department of Medical Science, Teijin Pharma Limited
  3. 3Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry
  1. ↵*Corresponding author: Yoshihiro Noda, M.D., Ph.D., M.B.A.
    , Clinician Scientist, Multidisciplinary Translational Research Lab, Associate Professor, Department of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan, Tel.: +81-3-3353-1211, E-mail: yoshi-tms{at}keio.jp
Back to top
Posted December 06, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Cost-effectiveness analysis comparing repetitive transcranial magnetic stimulation therapy with antidepressant treatment in patients with treatment-resistant depression in Japan
Yoshihiro Noda, Chiaki Miyashita, Yoko Komatsu, Shinsuke Kito, Masaru Mimura
medRxiv 2022.12.02.22282995; doi: https://doi.org/10.1101/2022.12.02.22282995
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area